抑郁症状与新发心血管疾病的关联
该研究 pooled 分析了 ERFC 和 UK Biobank 共 563 255 名无心血管疾病史参与者的个体数据,发现基线抑郁症状与冠心病、卒中及复合心血管疾病发病风险呈对数线性正相关,且关联在低于抑郁障碍阈值的症状水平即存在,但效应量较小。
要点
- 抑郁症状每升高 1 个标准差,冠心病风险 HR 为 1.07–1.11。
- 抑郁症状与卒中风险的关联 similarly modest,HR 为 1.05–1.10。
- 低于抑郁障碍阈值的症状水平也与心血管疾病风险升高相关。
核心结论
- 基线抑郁症状与心血管疾病发病风险独立相关,但关联强度较小。
研究设计与样本
- 研究 pooled 分析了 ERFC(162 036 人,21 个队列)和 UK Biobank(401 219 人)的个体参与者数据。
- ERFC 基线调查为 1960–2008 年,UK Biobank 为 2006–2010 年,最新随访至 2020 年 3 月。
- 纳入标准为有抑郁症状自评信息且基线无心血管疾病史。
主要发现
- ERFC 中位随访 9.5 年,记录 5078 例冠心病和 3932 例卒中事件。
- ERFC 抑郁评分每升高 1 SD 的冠心病 HR 为 1.07(95%CI 1.03–1.11),卒中 HR 为 1.05(95%CI 1.01–1.10),心血管疾病 HR 为 1.06(95%CI 1.04–1.08)。
- UK Biobank 中位随访 8.1 年,记录 4607 例冠心病和 3253 例卒中事件。
- UK Biobank 抑郁评分每升高 1 SD 的冠心病 HR 为 1.11(95%CI 1.08–1.14),卒中 HR 为 1.10(95%CI 1.06–1.14),心血管疾病 HR 为 1.10(95%CI 1.08–1.13)。
- 调整更多危险因素后,HR 的幅度和统计显著性无实质性变化。
关键数值与推荐
- ERFC 使用 CES-D 量表(范围 0–60,≥16 提示可能抑郁障碍),UK Biobank 使用 PHQ-2(范围 0–6,≥3 提示可能抑郁障碍)。
- ERFC 中 CES-D 最高五分位(几何均值 19)与最低五分位(几何均值 1)相比,冠心病发病率 36.3 vs 29.0/万人年,卒中 28.0 vs 24.7/万人年,心血管疾病 62.8 vs 53.5/万人年。
- UK Biobank 中 PHQ-2≥4 与 0 分相比,冠心病发病率 20.9 vs 14.2/万人年,卒中 15.3 vs 10.2/万人年,心血管疾病 36.2 vs 24.5/万人年。
临床怎么用
- 抑郁症状评估可能有助于识别心血管疾病风险轻度升高的人群。
- 不应仅凭抑郁症状水平启动强化心血管预防,需结合整体风险评估。
局限性
- 原文未报告
- 原文未报告
- 原文未报告
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: It is uncertain whether depressive symptoms are independently associated with subsequent risk of cardiovascular diseases (CVDs). OBJECTIVE: To characterize the association between depressive symptoms and CVD incidence across the spectrum of lower mood. DESIGN, SETTING, AND PARTICIPANTS: A pooled analysis of individual-participant data from the Emerging Risk Factors Collaboration (ERFC; 162 036 participants; 21 cohorts; baseline surveys, 1960-2008; latest follow-up, March 2020) and the UK Biobank (401 219 participants; baseline surveys, 2006-2010; latest follow-up, March 2020). Eligible participants had information about self-reported depressive symptoms and no CVD history at baseline. EXPOSURES: Depressive symptoms were recorded using validated instruments. ERFC scores were harmonized across studies to a scale representative of the Center for Epidemiological Studies Depression (CES-D) scale (range, 0-60; ≥16 indicates possible depressive disorder). The UK Biobank recorded the 2-item Patient Health Questionnaire 2 (PHQ-2; range, 0-6; ≥3 indicates possible depressive disorder). MAIN OUTCOMES AND MEASURES: Primary outcomes were incident fatal or nonfatal coronary heart disease (CHD), stroke, and CVD (composite of the 2). Hazard ratios (HRs) per 1-SD higher log CES-D or PHQ-2 adjusted for age, sex, smoking, and diabetes were reported. RESULTS: Among 162 036 participants from the ERFC (73%, women; mean age at baseline, 63 years [SD, 9 years]), 5078 CHD and 3932 stroke events were recorded (median follow-up, 9.5 years). Associations with CHD, stroke, and CVD were log linear. The HR per 1-SD higher depression score for CHD was 1.07 (95% CI, 1.03-1.11); stroke, 1.05 (95% CI, 1.01-1.10); and CVD, 1.06 (95% CI, 1.04-1.08). The corresponding incidence rates per 10 000 person-years of follow-up in the highest vs the lowest quintile of CES-D score (geometric mean CES-D score, 19 vs 1) were 36.3 vs 29.0 for CHD events, 28.0 vs 24.7 for stroke events, and 62.8 vs 53.5 for CVD events. Among 401 219 participants from the UK Biobank (55% were women, mean age at baseline, 56 years [SD, 8 years]), 4607 CHD and 3253 stroke events were recorded (median follow-up, 8.1 years). The HR per 1-SD higher depression score for CHD was 1.11 (95% CI, 1.08-1.14); stroke, 1.10 (95% CI, 1.06-1.14); and CVD, 1.10 (95% CI, 1.08-1.13). The corresponding incidence rates per 10 000 person-years of follow-up among individuals with PHQ-2 scores of 4 or higher vs 0 were 20.9 vs 14.2 for CHD events, 15.3 vs 10.2 for stroke events, and 36.2 vs 24.5 for CVD events. The magnitude and statistical significance of the HRs were not materially changed after adjustment for additional risk factors. CONCLUSIONS AND RELEVANCE: In a pooled analysis of 563 255 participants in 22 cohorts, baseline depressive symptoms were associated with CVD incidence, including at symptom levels lower than the threshold indicative of a depressive disorder. However, the magnitude of associations was modest.
引用
- Harshfield EL, Pennells L, Schwartz JE, et al. Association Between Depressive Symptoms and Incident Cardiovascular Diseases. JAMA. 2020. PMID: 33320224. doi:10.1001/jama.2020.23068
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。